Hennion & Walsh Asset Management »

C4 Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $818k 227k 3.60
2024-09-30 $1.1M 192k 5.70
2024-06-30 $660k 143k 4.62

More positions owned by Hennion & Walsh Asset Management

Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Proshares Tr S&p 500 High Inc (ISPY)
Ishares Tr Investment Grade (IGEB)
Wisdomtree Tr Intl Qulty Div (IQDG)
Ishares Tr Core S&p500 Etf (IVV)
Global X Fds Us Pfd Etf (PFFD)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Wisdomtree Tr Us S Cap Qty Div (DGRS)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Nuveen Insured Tax-Free Adv Munici (NEA)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Apple (AAPL)

View all positions for Hennion & Walsh Asset Management

Top funds holding C4 Therapeutics

Soleus Capital Management
Lynx1 Capital Management
Daniel D. Thurber
BlackRock
RA Capital Management
OrbiMed Advisors
Morgan Stanley
Commodore Capital
Vanguard Group
Samlyn Capital
Bank of America Corporation
Adage Capital Partners GP
Geode Capital Management
Arrowpoint Asset Management
Silverarc Capital Management

View all funds holding C4 Therapeutics